APA Citatie

Katz, A., Barash, U., Boyango, I., Feld, S., Zohar, Y., Hammond, E., . . . Vlodavsky, I. (2018). Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer. Oncotarget.

Chicago Style citaat

Katz, Amit, Uri Barash, Ilanit Boyango, Sari Feld, Yaniv Zohar, Edward Hammond, Neta Ilan, Ran Kremer, en Israel Vlodavsky. "Patient Derived Xenografts (PDX) Predict an Effective Heparanase-based Therapy for Lung Cancer." Oncotarget 2018.

MLA citatie

Katz, Amit, et al. "Patient Derived Xenografts (PDX) Predict an Effective Heparanase-based Therapy for Lung Cancer." Oncotarget 2018.